Published in World J Gastroenterol on February 28, 2013
Retracted Mitoneet mediates TNFα-induced necroptosis promoted by exposure to fructose and ethanol. J Cell Sci (2013) 1.67
The de ritis ratio: the test of time. Clin Biochem Rev (2013) 1.14
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review. Circulation (2016) 1.13
Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2014) 1.07
Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients (2014) 0.92
De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol Rev Camb Philos Soc (2015) 0.91
Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr (2015) 0.90
The influence of dietary fat on liver fat accumulation. Nutrients (2014) 0.90
CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). Semin Immunopathol (2013) 0.87
Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet. PLoS One (2015) 0.86
Hepatic function and the cardiometabolic syndrome. Diabetes Metab Syndr Obes (2013) 0.83
From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. Am J Physiol Endocrinol Metab (2014) 0.81
Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of Non-Alcoholic Fatty Liver Disease. PLoS One (2013) 0.81
Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World J Gastroenterol (2015) 0.80
Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. Mamm Genome (2014) 0.80
Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. World J Hepatol (2014) 0.79
A current update on the rule of alternative and complementary medicine in the treatment of liver diseases. Evid Based Complement Alternat Med (2013) 0.79
Docosahexaenoic Acid Ameliorates Fructose-Induced Hepatic Steatosis Involving ER Stress Response in Primary Mouse Hepatocytes. Nutrients (2016) 0.79
The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose? Open Heart (2014) 0.78
Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice. Nutrients (2016) 0.78
Metabolomic Characterizations of Liver Injury Caused by Acute Arsenic Toxicity in Zebrafish. PLoS One (2016) 0.77
Comparative study of the modulation of fructose/sucrose-induced hepatic steatosis by mixed lipid formulations varying in unsaturated fatty acid content. Nutr Metab (Lond) (2015) 0.77
Modulation of IKKβ/NF-κB and TGF-β1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice. Iran J Basic Med Sci (2015) 0.77
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism (2016) 0.77
AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease. Mol Ther Methods Clin Dev (2014) 0.76
Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice. Sci Rep (2016) 0.75
Sodium 4-phenylbutyrate prevents murine dietary steatohepatitis caused by trans-fatty acid plus fructose. J Clin Biochem Nutr (2015) 0.75
Individual CLA Isomers, c9t11 and t10c12, Prevent Excess Liver Glycogen Storage and Inhibit Lipogenic Genes Expression Induced by High-Fructose Diet in Rats. Biomed Res Int (2015) 0.75
Quelling Inflammation with Ketosis and Steric Chemistry. Clin Transl Gastroenterol (2016) 0.75
Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. World J Hepatol (2016) 0.75
A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model. PLoS One (2016) 0.75
Fructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic Metabolism. Nutrients (2017) 0.75
Liver ubiquitome uncovers nutrient-stress-mediated trafficking and secretion of complement C3. Cell Death Dis (2016) 0.75
Vanadium methyl-bipyridine organoligand and its influence on energy balance and organs mass. Biol Trace Elem Res (2014) 0.75
Lipogenesis in Huh7 cells is promoted by increasing the fructose: Glucose molar ratio. World J Hepatol (2016) 0.75
High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice. J Clin Exp Hepatol (2016) 0.75
Temporal metabolomic responses of cultured HepG2 liver cells to high fructose and high glucose exposures. Metabolomics (2015) 0.75
Transient Decrease in Circulatory Testosterone and Homocysteine Precedes the Development of Metabolic Syndrome Features in Fructose-Fed Sprague Dawley Rats. J Nutr Metab (2016) 0.75
The relationship between sugar-sweetened beverages and liver enzymes among healthy premenopausal women: a prospective cohort study. Eur J Nutr (2015) 0.75
CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia. J Mol Med (Berl) (2017) 0.75
eIF2α phosphorylation is required to prevent hepatocyte death and liver fibrosis in mice challenged with a high fructose diet. Nutr Metab (Lond) (2017) 0.75
Endocrine-disrupting chemicals and fatty liver disease. Nat Rev Endocrinol (2017) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 13.42
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology (1999) 11.76
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology (2003) 9.36
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest (2005) 9.09
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology (2003) 8.75
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. BMJ (2004) 7.01
Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab (2002) 6.79
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation (2007) 6.34
Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med (1999) 5.65
Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr (2002) 5.13
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest (2002) 4.96
Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology (1999) 3.99
Liver fibrosis in overweight patients. Gastroenterology (2000) 3.56
Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab (2004) 3.54
The epidemic of obesity. J Clin Endocrinol Metab (2004) 3.53
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology (2002) 3.29
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology (2004) 3.23
Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol (2008) 2.45
Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes (2005) 2.43
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology (2002) 2.02
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology (2000) 1.96
Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr (2012) 1.80
Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab (2004) 1.70
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol (2011) 1.48
Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol (2010) 1.40
Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol (2010) 1.40
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl (2001) 1.38
Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity (Silver Spring) (2006) 1.37
Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest (2005) 1.33
Lipid metabolism in hepatic steatosis. Clin Liver Dis (2004) 1.22
Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. Diabetes (2012) 1.13
Expression patterns of genes involved in sugar metabolism and accumulation during apple fruit development. PLoS One (2012) 1.12
Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice. Hepatology (2010) 1.12
Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol Res (2005) 1.08
Does fructose consumption contribute to non-alcoholic fatty liver disease? Clin Res Hepatol Gastroenterol (2012) 1.01
High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metabolism (2012) 1.00
Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J Gastroenterol (2009) 0.95
Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. World J Gastroenterol (2011) 0.93
Fructose and risk of cardiometabolic disease. Curr Atheroscler Rep (2012) 0.92
Hepatotoxicity of fast food? Gut (2008) 0.91
Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. Br J Nutr (2012) 0.88
Hepatoprotective actions of melatonin: possible mediation by melatonin receptors. World J Gastroenterol (2010) 0.87
Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools. Lipids (2012) 0.86
Stimulation of fat accumulation in hepatocytes by PGE₂-dependent repression of hepatic lipolysis, β-oxidation and VLDL-synthesis. Lab Invest (2012) 0.86
Metabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolites. Int J Mol Sci (2011) 0.84
Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care (2012) 0.84
Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice. J Lipid Res (2011) 0.83
Dietary approach in the prevention and treatment of NAFLD. Front Biosci (Landmark Ed) (2012) 0.82
Indole-based fibrates as potential hypolipidemic and antiobesity agents. J Med Chem (2012) 0.81
Effects of excessive fructose intake on health. Ann Intern Med (2012) 0.81
Effects of dietary fat energy restriction and fish oil feeding on hepatic metabolic abnormalities and insulin resistance in KK mice with high-fat diet-induced obesity. J Nutr Biochem (2012) 0.77
The metabolic syndrome of fructose-fed rats: effects of long-chain polyunsaturated ω3 and ω6 fatty acids. IV. D-glucose metabolism by isolated pancreatic islets. Int J Mol Med (2011) 0.76
Opposite fates of fructose in the development of metabolic syndrome. World J Gastroenterol (2012) 0.76
Transient urinary incontinence after subarachnoid anesthesia with 0.5% heavy bupivacaine. Anesth Analg (2006) 1.38
From fatty liver to fibrosis: a tale of "second hit". World J Gastroenterol (2013) 1.26
Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults. Arch Med Sci (2013) 0.99
Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats. Cell Biochem Funct (2003) 0.96
Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis. BMC Gastroenterol (2005) 0.95
The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients. Eur J Intern Med (2011) 0.91
An approach to infraclavicular brachial plexus block: the highest point of the shoulder as a reference. Anesth Analg (2006) 0.86
Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation. Eur J Endocrinol (2009) 0.86
Concordance of endoscopic ultrasonography-guided fine needle aspiration diagnosis with the final diagnosis in subepithelial lesions. Clin Endosc (2013) 0.83
Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients. Nutr Metab Cardiovasc Dis (2007) 0.83
The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus. J Diabetes Complications (2005) 0.82
The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration. Wien Klin Wochenschr (2014) 0.80
Tongue swelling in a child after cleft palate surgery. Middle East J Anaesthesiol (2009) 0.79
The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism. Endocr Res (2012) 0.79
Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease? Neuromuscul Disord (2009) 0.78
Serum paraoxonase enzyme activity and oxidative stress in obese subjects. Pol Arch Med Wewn (2011) 0.78
Selective spinal anesthesia for limb amputation above knee level. J Clin Anesth (2011) 0.78
Preventive role of gallic acid on alcohol dependent and cysteine protease-mediated pancreas injury. Mol Biol Rep (2012) 0.76
High serum concentration of interleukin-18 in diabetic patients with foot ulcers. J Am Podiatr Med Assoc (2014) 0.76
Endosonography and elastography in the diagnosis of esophageal tuberculosis. Turk J Gastroenterol (2013) 0.76
Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus. Clin Invest Med (2003) 0.76
Regional block anesthesia in a patient with factor V Leiden mutation and axillary artery occlusion. Local Reg Anesth (2011) 0.75
Serum prolidase activity in diabetic foot ulcers. Acta Diabetol (2012) 0.75
Vater's papillary stenosis in a child with abdominal pain. Pediatr Int (2006) 0.75
The effects of calcium channel blockers on nephropathy and pigment epithelium-derived factor in the treatment of hypertensive patients with type 2 diabetes mellitus. Clin Exp Hypertens (2014) 0.75
Inadvertent venous air embolism during cesarean section: collapsible intravenous fluid bags without self-sealing outlet have risks. Case report. Braz J Anesthesiol (2013) 0.75
Recurrent symptomatic hypocalcemia during rifampicin therapy for brucellosis. Wien Klin Wochenschr (2011) 0.75
The effect of Trifolium, Raphanus, and Cistus pollen grains on some blood parameters and mesentery mast cells. Z Naturforsch C (2006) 0.75
Sidewise mask ventilation for pediatric anesthesia. Rev Bras Anestesiol (2012) 0.75
Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C. Turk J Gastroenterol (2014) 0.75
Comment on: Selective Serotonin Reuptake Inhibitor-Induced Hyponatremia: Clinical Implications and Therapeutic Alternatives. Clin Neuropharmacol (2017) 0.75